Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perineal leiomyosarcoma.

J P Rice1, D C MacGillivray, R W Sharpe

  • 1Department of General Surgery, National Naval Medical Center, Bethesda, Maryland.

Gynecologic Oncology
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Perineal leiomyosarcomas are rare, aggressive tumors. Management is challenging due to extensive infiltration and difficulty achieving adequate surgical margins, similar to retroperitoneal sarcomas.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalized Electrical Substitution Methods and Detectors for Absolute Optical Power Measurements.

Metrologia·2023
Same author

Development of electrical substitution Fourier transform spectrometry for absolute optical power measurements.

Optics express·2021
Same author

Genome-wide association study identifies a novel locus for cannabis dependence.

Molecular psychiatry·2017
Same author

Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.

Molecular psychiatry·2017
Same author

Genetic effects influencing risk for major depressive disorder in China and Europe.

Translational psychiatry·2017
Same author

Spectrally Tunable Sources for Advanced Radiometric Applications.

Journal of research of the National Institute of Standards and Technology·2016
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Surgical Oncology
  • Rare Tumors

Background:

  • Perineal leiomyosarcomas are uncommon and aggressive malignancies.
  • Treatment strategies for these tumors are not well-established.
  • Tumor infiltration and proximity to vital structures pose significant surgical challenges.